Lyndsay J . Willmott, MD
Assistant Professor
![](https://dms.creighton.edu/sites/default/files/faculty-images/cu-profile-generic_1.jpg)
Contact
School of Medicine
Obstetrics and Gynecology Residency
Arizona Health
Lyndsay J . Willmott, MD
Assistant Professor
Department
Obstetrics & Gynecology (Phoenix)
Position
Assistant Professor
Publications
- Clinical cancer research
Lorentzen Georgia M, Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification 2024 - Journal of minimally invasive gynecology
Stewart Chelsea, Factors associated with inpatient narcotic medication usage after robotic assisted laparoscopy 2023 - Journal of geriatric oncology
Moore Madison S., Robotic-assisted gynecologic surgery in an older population: A comparison study
14:6, p. 101533 - 101533 2023 - International journal of gynecological cancer
Oaknin Ana, 2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246)
32:Suppl 2, p. A472 - A472 2022 - Gynecologic oncology
Eakin C., Cervical Cancer Screening in Pregnancy: Identifying Characteristics of Poor Postpartum Follow-up
156:3, p. e36 - e36 2020 - Gynecologic oncology
Barnes Dominique, Clinic-based Depression Screening in Gynecologic Oncology Patients using the Patient Health Questionnaires-2 (PHQ-2): are we identifying the highest risk patients?
147:1, p. 215 - 215 2017 - Gynecologic oncology
Vo E.H., Robotic-assisted Gynecologic Surgery in an Elderly Population: A Comparison Study
147:1, p. 204 - 205 2017 - Gynecologic oncology
Moreno A., Factors Associated with Increased Narcotic Usage after Undergoing Robotic Assisted Laparoscopy
147:1, p. 203 - 203 2017 - Gynecologic oncology
Barnes Dominique, Patient characteristics associated with obesity in an endometrial cancer patient: first steps towards the design of a weight loss intervention
147:1, p. 215 - 215 2017 - Journal of clinical oncology
Love Neil, The morbidity and mortality conference (MMC) concept applied to contemporary oncology practice: Retrospective findings on management of 233 patients (pts) who died of ovarian cancer (OC), colorectal cancer (CRC), and wild-type (no identified targetable mu
35:8_suppl, p. 241 - 241 2017 - Gynecologic oncology research and practice
Minion Lindsey E., Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study
3:1, p. 4 - 4 2016 - Journal of gynecologic surgery
Shields Kristin M., Ten-Year Food and Drug Administration Reporting on Robotic Complications in Gynecologic Surgery
31:6, p. 331 - 335 2015 - Gynecologic oncology
Shields K.M., Factors associated with low educational background in uterine cancer patients
137, p. 123 - 123 2015 - Gynecologic oncology
Craig C., The characteristics and associations of pelvic pain in gynecologic cancer patients: A single institution study
131:1, p. 264 - 264 2013 - Angiogenesis (London)
Trapp Valerie, Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture
13:4, p. 305 - 315 2010 - Cancer research (Chicago, Ill.)
Willmott Lyndsay J., Abstract 1399: The effect of radiation therapy with adjunctive oxaliplatin versus cisplatin chemotherapy in cervical cancer cell lines
70:8_Supplement, p. 1399 - 1399 2010 - Gynecologic oncology
Monk Bradley J., Anti-angiogenesis agents in metastatic or recurrent cervical cancer
116:2, p. 181 - 186 2010 - Journal of the National Comprehensive Cancer Network
Willmott L. J., Biologics in Cervical Cancer Therapy
8:12, p. 1417 - 1423 2010 - Journal of oncology
Willmott Lyndsay J., Targeted Therapy in Ovarian Cancer
2010, p. 740472 - 9 2010 - Expert review of anticancer therapy
Willmott Lyndsay J, Cervical cancer therapy: current, future and anti-angiogensis targeted treatment
9:7, p. 895 - 903 2009